Advertisement.
Advertisement.
Advertisement
Advertisement.
PAHC Phibro Animal Health Corp. - Ordinary Shares - Class A
210
| Market Cap | $762.68M |
| Volume | 108,862.00 |
| 52-Wk High | $19.55 |
| 52-Wk Low | $9.40 |
Phibro Upgraded to Strong Buy: What Does It Mean for the Stock?
Benzinga•1 month ago
Phibro Animal Health (NASDAQ: PAHC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in...
Share to Feed
Phibro Animal Health Corporation (Nasdaq: PAHC) proudly announces its third annual Environmental, Social and Governance (ESG) Report, highlighting 2023 achievements. At Phibro, the connections...
Business Wire•2 months ago
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Annual Dental and Animal Health (Jaws & Paws) Conference. Chief Financial Officer, Glenn David along...
Business Wire•2 months ago
Phibro Animal Health Corporation (Nasdaq: PAHC) (Phibro or the Company) today announced financial results for its third quarter ended March 31, 2024, and its updated financial guidance for the year...
Business Wire•3 months ago
The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on...
Business Wire•3 months ago
Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis medicated...
Business Wire•3 months ago
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 8, 2024, after the market closes. Phibro management will host a conference...
Business Wire•3 months ago
StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC - Free Report) from a hold rating to a buy rating in a report released on Friday. Separately, BNP Paribas began coverage on shares...
Ticker Report•4 months ago
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) was upgraded by research analysts at StockNews.com from a "hold" rating to a "buy" rating in a report issued on Friday.
Separately, BNP Paribas...
Zolmax•4 months ago
Phibro Animal Health Co. (NASDAQ:PAHC Free Report) Analysts at Zacks Research lifted their Q2 2025 earnings per share (EPS) estimates for Phibro Animal Health in a research note...
Zolmax•4 months ago